Original article
Thrombus composition in acute ischemic stroke: A histopathological study of thrombus extracted by endovascular retrieval

https://doi.org/10.1016/j.neurad.2014.01.124Get rights and content

Summary

Background and purpose

The composition of occlusive thrombus in acute ischemic stroke may affect treatment success. Neuroimaging characteristics may correlate with thrombus composition. In this study we aimed to investigate the relationship between the hyperdense artery sign (HAS) on imaging and thrombus composition.

Materials and methods

Acute ischemic stroke patients who underwent endovascular thrombus retrieval from 2010–2012 were prospectively recruited. One blinded pathologist prepared the histology sections of retrieved thrombi whereby staining with haematoxylin and eosin and CD34 immunostain were performed. Histology sections were categorised into 4 phases of thrombus formation: red blood cell (RBC) dominant, RBC proportion equal to fibrin, fibrin dominant and organised fibrin. Computed tomography (CT) brain scans were assessed for HAS. Fisher's exact test was performed to identify an association between HAS and thrombus composition.

Results

Forty patients were included. The mean age was 65.6 ± 12.9 years and 67.5% were male. Atrial fibrillation was detected in 19 (47.5%) patients, diabetes mellitus in 6 (15.0%), hypercholesterolaemia in 11 (27.5%), hypertension in 20 (50.0%) and previous stroke or transient ischemic attack in 8 (20.0%) patients. Of the retrieved thrombi, 11 (27.5%) were RBC dominant, 11 (27.5%) RBC proportion was equal to fibrin, 7 (17.5%) fibrin dominant and 11 (27.5%) organised fibrin pathology. HAS was present in 29 (72.5%) patients and was significantly associated with thrombus early phase pathology (P < 0.05).

Conclusion

HAS was significantly associated with early phase thrombus composition. This may enable the prediction of thrombus composition and allow for targeted selection of therapeutic modality.

Introduction

The most effective treatment for acute ischemic stroke is reperfusion therapy [1], [2]. Current guidelines recommend IV tPA as the primary reperfusion therapy, based on randomised controlled studies, demonstrating improved clinical outcomes [1], [3], [4]. However, IV tPA is associated with high recanalisation failure rates. In particular, recanalisation of an occluded ICA occurs at only 4.4% and recanalisation of the basilar artery occurs at only 4% [5].

It has been postulated that IV tPA is more effective on thrombus in the early phases of formation and organisation, suggesting that thrombus composition may be the mechanism of recanalisation failure. [6], [7], [8], [9], [10], [11], [12]. Previous research has demonstrated time dependant histological phases of thrombus formation with the formation of a “white thrombus”, composed mainly of fibrin and platelets, being the first phase [13], [14], [15], [16]. In comparison, thrombi of late phase formation, involving the formation of a “red thrombus”, are composed mainly of fibrin and RBC [15], [16]. It is possible that the decreased efficacy of IV tPA on late phase thrombus is attributable to the organisation of fibrin within the “red thrombus”. A surrogate marker for organised fibrin is the presence of endothelial cell proliferation which can be detected with CD34 immunostain [17], [18], [19]. This novel technique enables the identification of potentially resistant thrombi in the late phases of formation.

Clinical evidence has shown that treatment efficacy for stroke is time-dependant, given that patients demonstrate better clinical outcomes when treatment is administered at the earliest opportunity [1], [20], [21], [22]. Knowledge of occlusive thrombus composition prior to treatment may enable clinicians to predict the patient's response to IV tPA and aid in more rapid selection of the most appropriate revascularisation strategy. There is emerging interest in utilising radiologic imaging characteristics as predictors of thrombus composition [23].

Advances in thrombus retrieval technology offers an opportunity to directly examine the occlusive thrombi retrieved from acute ischemic stroke patients [24]. This opens the possibility of correlating thrombus composition with pre-treatment neuroimaging. In this study, we investigated the relationship between radiologic imaging characteristics and thrombus composition. We hypothesised that the presence of HAS, determined by visual asymmetrical increased density of a cerebral artery on plain CT, is associated with the early phases of thrombus formation.

Section snippets

Materials and methods

This study was approved by the Human Research Ethics Committee. Forty acute ischemic stroke patients who underwent thrombus retrieval at our hospital between November 2010 and December 2012 were included in this study. Subjects presented with an acute ischemic stroke, defined by onset < 6 hours, and underwent routine plain CT upon arrival. IV tPA (Alteplase) (Boehringer Ingelheim; Ingelheim, Germany) treatment (0.9 mg per kilogram of body weight) was administered to eligible patients prior to

Results

Forty acute ischemic stroke patients fulfilled the selection criteria and were included in this study. Of the study population, 27 (67.5%) patients were male and the mean age at presentation was 65.6 (SD ± 12.9) years. The Solitaire™ FR revascularization device was used in 40 (100%) cases and 28 (70.0%) patients received IV tPA prior to undergoing thrombus retrieval. Fourteen (35.0%) patients had an ICA occlusion, 22 (55.0%) had a MCA occlusion and 4 (10.0%) had an occlusion in the basilar

Discussion

It has been proven that time to treatment is a critical determinant of thrombolysis efficacy. Patients achieve better clinical outcomes when treatment is administered at the earliest opportunity [1], [20], [21], [22]. Failure of vessels to reanalyse is thought to be due to thrombus composition, with early phase thrombi responding better to IV tPA [6], [7], [8], [9], [10], [11], [12] The results of our study showed a significant association between visual inspection of HAS and early phase

Conclusion

We conclude that thrombi composed of early phase pathology are associated with HAS on pre-treatment plain CT scans. The implications of this finding is that the presence or absence of HAS on pre-treatment plain CT scans may enable clinicians to predict the composition of the occlusive thrombi and the effectiveness of treatment options.

Disclosure of interest

The authors declare that they have no conflicts of interest concerning this article.

Acknowledgements

We thank Ms. Christine Pang for her efforts in collecting part of the clinical data.

References (33)

  • A.M. Muller et al.

    Expression of the endothelial markers PECAM-1, VWf and CD34 in vivo and in vitro

    Exp Mol Pathol

    (2002)
  • H. Raoult et al.

    Prognostic factors for outcomes after mechanical thrombectomy with solitaire stent

    J Neuroradiol

    (2013)
  • K.O. Lovblad et al.

    Neuro-imaging of cerebral ischemic stroke

    J Neuroradiol

    (2008)
  • Y. Sato et al.

    Thrombus components in cardioembolic and atherothrombotic strokes

    Thromb Res

    (2012)
  • The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study

    Tissue plasminogen activator for acute ischemic stroke

    N Engl J Med

    (1995)
  • W.M. Clark et al.

    Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase thrombolysis for acute non-interventional therapy in ischemic stroke

    JAMA J Am Med Assoc

    (1999)
  • American Heart Association

    Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists

    Stroke

    (2007)
  • European Stroke Organisation

    Guidelines for management of ischemic stroke and transient ischemic attack 2008 – The European Stroke Organisation (ESO) Executive Committee and the ESO Writing Committee

    Cerebrovasc Dis

    (2008)
  • R. Bhatia et al.

    Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action

    Stroke

    (2010)
  • I.K. Jang et al.

    Differential sensitivity of erythrocyte-rich and platelet-rich arterial thrombi to lysis with recombinant tissue-type plasminogen activator. A possible explanation for resistance to coronary thrombolysis

    Circulation

    (1989)
  • A. Blinc et al.

    Dependence of blood thrombus lysis on the mode of transport of urokinase into the thrombus – a magnetic resonance imaging study in vitro

    Thromb Haemost

    (1991)
  • A. Blinc et al.

    Magnetic resonance imaging of retracted and non-retracted blood thrombi during fibrinolysis in vitro

    Haemostasis

    (1992)
  • J.H. Wu et al.

    Transport phenomena and thrombus dissolution therapy: an experimental investigation of diffusion-controlled and permeation-enhanced fibrinolysis

    J Thromb Haemost

    (1994)
  • F. Niessen et al.

    Differences in thrombus preparation determine outcome of recombinant tissue plasminogen activator treatment in experimental thromboembolic stroke

    Stroke

    (2003)
  • K. Kirchhof et al.

    Differentiation of white, mixed, and red thrombi: value of CT in estimation of the prognosis of thrombolysis – Phantom Study1

    Radiology

    (2003)
  • K. Kirchhof et al.

    Does the result of thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in rabbits depend on the erythrocyte- and fibrin-content of a thrombus?

    Rofo

    (2004)
  • Cited by (0)

    View full text